In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).
Maschio
M
M
Dinapoli
L
L
Jandolo
B
B
D001932:Brain Neoplasms / Q000188:drug therapy*; D006801:Humans; D000077287:Levetiracetam; D018697:Nootropic Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011446:Prospective Studies
D018697:Nootropic Agents; D000077287:Levetiracetam; D010889:Piracetam
Lancet Neurol. 2007 May;6(5):421-30
17434097
J Neurooncol. 2006 Oct;80(1):97-100
16685465
Semin Oncol. 2003 Dec;30(6 Suppl 19):49-52
14765386
Clin Ther. 2008 Aug;30(8):1385-407
18803983
J Neurooncol. 2010 Sep;99(2):251-60
20146087
Curr Neurol Neurosci Rep. 2005 May;5(3):207-13
15865886
J Child Neurol. 2002 Jan;17 Suppl 1:S53-7
11918464
Lancet Neurol. 2003 Aug;2(8):473-81
12878435
Clin Pharmacokinet. 2004;43(11):707-24
15301575
Seizure. 2003 Dec;12(8):585-6
14630498